For Canadians researching ibogaine, the federal starting point is the Controlled Drugs and Substances Act (CDSA) and its regulations. Health Canada maintains the federal drug and substance framework, including notices and controlled-substance information that may affect possession, production, trafficking, importation, exportation, and authorization questions.
Ibogaine’s regulatory position should be checked against current official materials rather than inferred from a clinic’s description, a product label, or another country’s rules. The Controlled Drugs and Substances Act sets out the federal statute and includes the core prohibitions, offences, and authority structure relevant to controlled substances.
Classification language also requires care. A controlled-substance schedule, a drug authorization, a prescription, and a research authorization are different legal concepts with different effects. For a broader orientation to the substance itself, the ibogaine reference entry describes its origin and use history, but it is not a substitute for Canadian primary sources.